Concepts (275)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cochlear Implantation | 17 | 2024 | 51 | 6.200 |
Why?
|
Cochlear Implants | 11 | 2024 | 46 | 3.370 |
Why?
|
Neuroma, Acoustic | 9 | 2024 | 28 | 2.940 |
Why?
|
Cholesteatoma, Middle Ear | 5 | 2024 | 13 | 2.590 |
Why?
|
Hearing Loss, Sensorineural | 7 | 2020 | 135 | 2.420 |
Why?
|
Temporal Bone | 8 | 2021 | 35 | 2.080 |
Why?
|
Otologic Surgical Procedures | 7 | 2023 | 23 | 2.020 |
Why?
|
Hearing Loss | 5 | 2024 | 132 | 1.580 |
Why?
|
Mastoid | 5 | 2024 | 24 | 1.500 |
Why?
|
Tympanic Membrane | 2 | 2021 | 18 | 1.300 |
Why?
|
Cerebrospinal Fluid Otorrhea | 2 | 2021 | 5 | 1.280 |
Why?
|
Encephalocele | 4 | 2020 | 51 | 1.260 |
Why?
|
Fistula | 3 | 2021 | 50 | 1.230 |
Why?
|
Mastoidectomy | 2 | 2024 | 6 | 1.160 |
Why?
|
Speech Perception | 4 | 2024 | 48 | 1.100 |
Why?
|
Granuloma | 2 | 2016 | 69 | 1.010 |
Why?
|
Ear Canal | 2 | 2023 | 8 | 0.990 |
Why?
|
Cholesterol | 3 | 2016 | 517 | 0.960 |
Why?
|
Skull Base | 3 | 2021 | 50 | 0.920 |
Why?
|
Cholesteatoma | 1 | 2023 | 6 | 0.860 |
Why?
|
Cranial Sinuses | 2 | 2022 | 12 | 0.840 |
Why?
|
Ear, Middle | 4 | 2020 | 26 | 0.820 |
Why?
|
Tympanoplasty | 2 | 2024 | 9 | 0.790 |
Why?
|
Tomography, X-Ray Computed | 9 | 2021 | 1978 | 0.780 |
Why?
|
Ear Neoplasms | 3 | 2018 | 12 | 0.770 |
Why?
|
Retrospective Studies | 30 | 2024 | 15610 | 0.770 |
Why?
|
Hemangioma, Capillary | 1 | 2021 | 17 | 0.760 |
Why?
|
Adult | 39 | 2023 | 28621 | 0.750 |
Why?
|
Craniotomy | 3 | 2017 | 108 | 0.740 |
Why?
|
Ear, Inner | 1 | 2021 | 52 | 0.740 |
Why?
|
Hearing Loss, Bilateral | 1 | 2020 | 15 | 0.710 |
Why?
|
Magnetic Resonance Imaging | 9 | 2022 | 3432 | 0.710 |
Why?
|
Skull Neoplasms | 2 | 2017 | 15 | 0.700 |
Why?
|
Quality of Life | 3 | 2024 | 1896 | 0.680 |
Why?
|
Deafness | 1 | 2020 | 80 | 0.670 |
Why?
|
Middle Aged | 32 | 2021 | 25390 | 0.660 |
Why?
|
Petrous Bone | 2 | 2015 | 5 | 0.660 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 2 | 2015 | 10 | 0.640 |
Why?
|
Labyrinth Diseases | 1 | 2018 | 6 | 0.640 |
Why?
|
Semicircular Canals | 1 | 2018 | 21 | 0.630 |
Why?
|
Electrodes, Implanted | 2 | 2016 | 151 | 0.620 |
Why?
|
Female | 46 | 2024 | 64469 | 0.610 |
Why?
|
Neurotology | 1 | 2018 | 2 | 0.610 |
Why?
|
Humans | 69 | 2024 | 121732 | 0.600 |
Why?
|
Male | 44 | 2024 | 59115 | 0.590 |
Why?
|
Aged | 26 | 2020 | 18463 | 0.590 |
Why?
|
Postoperative Complications | 7 | 2023 | 2873 | 0.580 |
Why?
|
Plasmacytoma | 1 | 2017 | 7 | 0.570 |
Why?
|
Facial Nerve | 4 | 2023 | 25 | 0.550 |
Why?
|
Iatrogenic Disease | 2 | 2020 | 127 | 0.550 |
Why?
|
Tinnitus | 3 | 2022 | 19 | 0.550 |
Why?
|
Marital Status | 1 | 2016 | 34 | 0.540 |
Why?
|
Scala Tympani | 1 | 2016 | 3 | 0.540 |
Why?
|
Cranial Fossa, Middle | 1 | 2015 | 1 | 0.520 |
Why?
|
Vestibule, Labyrinth | 3 | 2023 | 42 | 0.510 |
Why?
|
Glomus Tympanicum Tumor | 1 | 2015 | 1 | 0.500 |
Why?
|
Brain Injuries, Traumatic | 1 | 2020 | 363 | 0.500 |
Why?
|
Treatment Outcome | 16 | 2024 | 11698 | 0.500 |
Why?
|
Surgical Mesh | 1 | 2015 | 61 | 0.490 |
Why?
|
Child | 18 | 2024 | 24035 | 0.490 |
Why?
|
Prednisone | 1 | 2015 | 272 | 0.490 |
Why?
|
Temporal Lobe | 1 | 2015 | 115 | 0.480 |
Why?
|
Fascia | 1 | 2014 | 15 | 0.480 |
Why?
|
Epilepsy, Temporal Lobe | 1 | 2015 | 84 | 0.470 |
Why?
|
Pancreatic Neoplasms | 2 | 2010 | 688 | 0.440 |
Why?
|
Perioperative Care | 1 | 2015 | 194 | 0.430 |
Why?
|
Suture Techniques | 1 | 2014 | 199 | 0.420 |
Why?
|
Facial Paralysis | 2 | 2023 | 37 | 0.420 |
Why?
|
Glucocorticoids | 1 | 2015 | 379 | 0.420 |
Why?
|
Drug Resistant Epilepsy | 1 | 2015 | 200 | 0.410 |
Why?
|
Hearing | 4 | 2023 | 51 | 0.390 |
Why?
|
Practice Patterns, Physicians' | 1 | 2018 | 712 | 0.390 |
Why?
|
Young Adult | 12 | 2021 | 8709 | 0.390 |
Why?
|
Pancreatectomy | 2 | 2010 | 134 | 0.390 |
Why?
|
Glomus Jugulare Tumor | 3 | 2016 | 4 | 0.380 |
Why?
|
Stapes Surgery | 2 | 2021 | 4 | 0.370 |
Why?
|
Vestibular Diseases | 2 | 2023 | 67 | 0.370 |
Why?
|
Adolescent | 14 | 2024 | 18875 | 0.370 |
Why?
|
Otolaryngologists | 2 | 2020 | 9 | 0.370 |
Why?
|
Carcinoma, Lobular | 1 | 2010 | 24 | 0.350 |
Why?
|
Seizures | 1 | 2015 | 873 | 0.350 |
Why?
|
Carcinoma, Renal Cell | 2 | 2010 | 235 | 0.350 |
Why?
|
Otolaryngology | 2 | 2020 | 101 | 0.320 |
Why?
|
Burnout, Professional | 2 | 2020 | 114 | 0.310 |
Why?
|
Radiosurgery | 4 | 2018 | 109 | 0.310 |
Why?
|
Reoperation | 3 | 2024 | 772 | 0.310 |
Why?
|
Kidney Neoplasms | 2 | 2010 | 425 | 0.300 |
Why?
|
Aged, 80 and over | 8 | 2020 | 6100 | 0.290 |
Why?
|
Head and Neck Neoplasms | 3 | 2019 | 469 | 0.280 |
Why?
|
Auditory Threshold | 2 | 2016 | 17 | 0.260 |
Why?
|
Child, Preschool | 9 | 2024 | 13766 | 0.250 |
Why?
|
Paraganglioma | 2 | 2014 | 19 | 0.240 |
Why?
|
Operative Time | 2 | 2016 | 150 | 0.240 |
Why?
|
Vestibular Function Tests | 2 | 2023 | 34 | 0.240 |
Why?
|
Multilingualism | 1 | 2024 | 43 | 0.230 |
Why?
|
Vestibular Evoked Myogenic Potentials | 1 | 2023 | 11 | 0.220 |
Why?
|
Mass Screening | 2 | 2021 | 776 | 0.220 |
Why?
|
Cautery | 1 | 2023 | 6 | 0.220 |
Why?
|
Endoscopy | 3 | 2016 | 279 | 0.210 |
Why?
|
Electrocoagulation | 1 | 2023 | 37 | 0.210 |
Why?
|
Incus | 1 | 2021 | 1 | 0.200 |
Why?
|
Bell Palsy | 1 | 2021 | 5 | 0.200 |
Why?
|
Earache | 1 | 2021 | 3 | 0.190 |
Why?
|
Stapedius | 1 | 2021 | 1 | 0.190 |
Why?
|
Hearing Loss, Conductive | 1 | 2021 | 12 | 0.190 |
Why?
|
Tendons | 1 | 2021 | 38 | 0.190 |
Why?
|
Otosclerosis | 1 | 2021 | 4 | 0.190 |
Why?
|
Audiometry | 2 | 2018 | 21 | 0.190 |
Why?
|
Breast Neoplasms | 2 | 2010 | 2486 | 0.180 |
Why?
|
Surveys and Questionnaires | 3 | 2021 | 3622 | 0.180 |
Why?
|
Cohort Studies | 4 | 2023 | 4632 | 0.180 |
Why?
|
Differential Threshold | 1 | 2020 | 11 | 0.180 |
Why?
|
Meningioma | 1 | 2022 | 110 | 0.180 |
Why?
|
Labyrinthitis | 1 | 2020 | 10 | 0.180 |
Why?
|
Hydrocephalus | 1 | 2023 | 236 | 0.180 |
Why?
|
Facial Nerve Diseases | 2 | 2021 | 6 | 0.170 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 173 | 0.170 |
Why?
|
Auditory Cortex | 1 | 2020 | 30 | 0.170 |
Why?
|
Physical Examination | 1 | 2021 | 162 | 0.170 |
Why?
|
Skull Base Neoplasms | 1 | 2019 | 35 | 0.170 |
Why?
|
Brain Stem | 1 | 2020 | 118 | 0.170 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 1873 | 0.160 |
Why?
|
SEER Program | 2 | 2016 | 192 | 0.160 |
Why?
|
Vestibulocochlear Nerve | 1 | 2018 | 6 | 0.150 |
Why?
|
Neurilemmoma | 1 | 2018 | 45 | 0.150 |
Why?
|
Intraoperative Neurophysiological Monitoring | 1 | 2018 | 13 | 0.150 |
Why?
|
Neuroendocrine Tumors | 1 | 2018 | 53 | 0.150 |
Why?
|
Postoperative Period | 2 | 2016 | 330 | 0.150 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2015 | 16 | 0.150 |
Why?
|
Otitis Media | 2 | 2014 | 82 | 0.140 |
Why?
|
Adenoma | 1 | 2018 | 134 | 0.140 |
Why?
|
Acoustic Impedance Tests | 1 | 2016 | 7 | 0.140 |
Why?
|
Electric Impedance | 1 | 2016 | 57 | 0.130 |
Why?
|
Audiology | 1 | 2016 | 5 | 0.130 |
Why?
|
Cross-Sectional Studies | 3 | 2020 | 3283 | 0.130 |
Why?
|
Granuloma, Foreign-Body | 1 | 2015 | 10 | 0.130 |
Why?
|
Ticlopidine | 1 | 2015 | 29 | 0.130 |
Why?
|
Audiometry, Pure-Tone | 1 | 2015 | 16 | 0.130 |
Why?
|
Neurosurgical Procedures | 2 | 2018 | 296 | 0.130 |
Why?
|
Eustachian Tube | 1 | 2015 | 5 | 0.130 |
Why?
|
Dizziness | 1 | 2015 | 27 | 0.130 |
Why?
|
Bone Plates | 1 | 2015 | 27 | 0.130 |
Why?
|
Papilloma, Inverted | 1 | 2015 | 2 | 0.130 |
Why?
|
Meningocele | 1 | 2015 | 20 | 0.130 |
Why?
|
Sex Distribution | 1 | 2016 | 283 | 0.130 |
Why?
|
Age Distribution | 1 | 2016 | 399 | 0.120 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2015 | 18 | 0.120 |
Why?
|
Headache | 1 | 2015 | 107 | 0.120 |
Why?
|
Glomus Tympanicum | 1 | 2014 | 2 | 0.120 |
Why?
|
Glomus Jugulare | 1 | 2014 | 1 | 0.120 |
Why?
|
Meningitis | 1 | 2015 | 99 | 0.120 |
Why?
|
Ear Diseases | 1 | 2015 | 18 | 0.120 |
Why?
|
Cranial Nerve Diseases | 1 | 2015 | 25 | 0.120 |
Why?
|
Skull Fractures | 1 | 2015 | 42 | 0.120 |
Why?
|
Cranial Nerve Neoplasms | 1 | 2014 | 8 | 0.120 |
Why?
|
Age of Onset | 1 | 2016 | 569 | 0.120 |
Why?
|
Meningitis, Pneumococcal | 1 | 2014 | 41 | 0.120 |
Why?
|
Warfarin | 1 | 2015 | 118 | 0.120 |
Why?
|
Autografts | 1 | 2014 | 26 | 0.120 |
Why?
|
Foreign-Body Migration | 1 | 2015 | 72 | 0.120 |
Why?
|
Adenocarcinoma | 2 | 2014 | 1003 | 0.120 |
Why?
|
Polyps | 1 | 2015 | 48 | 0.120 |
Why?
|
Aspirin | 1 | 2015 | 220 | 0.110 |
Why?
|
Prognosis | 4 | 2018 | 4477 | 0.110 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 254 | 0.110 |
Why?
|
United States | 3 | 2018 | 10415 | 0.110 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2022 | 1115 | 0.110 |
Why?
|
Models, Statistical | 1 | 2016 | 445 | 0.110 |
Why?
|
Odds Ratio | 1 | 2016 | 1226 | 0.110 |
Why?
|
Pneumococcal Vaccines | 1 | 2014 | 169 | 0.110 |
Why?
|
Sensitivity and Specificity | 1 | 2018 | 2007 | 0.110 |
Why?
|
Surgical Flaps | 1 | 2015 | 204 | 0.100 |
Why?
|
Brain Neoplasms | 1 | 2022 | 1218 | 0.100 |
Why?
|
Risk Assessment | 3 | 2016 | 3219 | 0.100 |
Why?
|
Hemorrhage | 1 | 2015 | 461 | 0.100 |
Why?
|
Research Design | 1 | 2015 | 643 | 0.100 |
Why?
|
Genetic Testing | 2 | 2015 | 989 | 0.100 |
Why?
|
Follow-Up Studies | 3 | 2016 | 4985 | 0.100 |
Why?
|
Reproducibility of Results | 3 | 2023 | 2795 | 0.090 |
Why?
|
Disease Management | 1 | 2015 | 512 | 0.090 |
Why?
|
Anticoagulants | 1 | 2015 | 581 | 0.090 |
Why?
|
Psychological Tests | 2 | 2020 | 90 | 0.090 |
Why?
|
Carcinoma, Ductal, Breast | 1 | 2010 | 82 | 0.090 |
Why?
|
Survival Analysis | 2 | 2014 | 1460 | 0.080 |
Why?
|
Infant | 4 | 2024 | 12268 | 0.080 |
Why?
|
Lung Neoplasms | 2 | 2010 | 1615 | 0.080 |
Why?
|
Keratotomy, Radial | 1 | 2009 | 33 | 0.080 |
Why?
|
Mitomycin | 1 | 2009 | 50 | 0.080 |
Why?
|
Vaccination | 1 | 2014 | 917 | 0.080 |
Why?
|
Photorefractive Keratectomy | 1 | 2009 | 80 | 0.080 |
Why?
|
Incidence | 1 | 2016 | 2985 | 0.080 |
Why?
|
Hyperopia | 1 | 2009 | 83 | 0.080 |
Why?
|
Case-Control Studies | 1 | 2015 | 3223 | 0.080 |
Why?
|
Cochlea | 2 | 2020 | 87 | 0.080 |
Why?
|
Self Report | 2 | 2020 | 492 | 0.070 |
Why?
|
Myopia | 1 | 2009 | 193 | 0.070 |
Why?
|
Visual Acuity | 1 | 2009 | 802 | 0.060 |
Why?
|
Child Language | 1 | 2024 | 29 | 0.060 |
Why?
|
Phonetics | 1 | 2024 | 40 | 0.060 |
Why?
|
Speech | 1 | 2024 | 53 | 0.060 |
Why?
|
Prevalence | 2 | 2020 | 2370 | 0.060 |
Why?
|
Caloric Tests | 1 | 2023 | 7 | 0.060 |
Why?
|
Schwann Cells | 1 | 2024 | 60 | 0.060 |
Why?
|
Vertigo | 1 | 2023 | 35 | 0.060 |
Why?
|
Prosthesis Failure | 1 | 2024 | 145 | 0.060 |
Why?
|
Ecosystem | 1 | 2024 | 76 | 0.060 |
Why?
|
Algorithms | 2 | 2022 | 1572 | 0.050 |
Why?
|
Head | 1 | 2023 | 102 | 0.050 |
Why?
|
Language | 1 | 2024 | 198 | 0.050 |
Why?
|
Arachnoid | 1 | 2022 | 8 | 0.050 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2023 | 48 | 0.050 |
Why?
|
Neoplasm Staging | 2 | 2018 | 1225 | 0.050 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 608 | 0.050 |
Why?
|
Face | 1 | 2023 | 181 | 0.050 |
Why?
|
Decision Trees | 1 | 2022 | 48 | 0.050 |
Why?
|
Chorda Tympani Nerve | 1 | 2021 | 2 | 0.050 |
Why?
|
Round Window, Ear | 1 | 2021 | 2 | 0.050 |
Why?
|
Ligaments | 1 | 2021 | 19 | 0.050 |
Why?
|
Bone Conduction | 1 | 2021 | 1 | 0.050 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 226 | 0.050 |
Why?
|
Prolapse | 1 | 2021 | 11 | 0.050 |
Why?
|
Intraoperative Period | 1 | 2021 | 73 | 0.050 |
Why?
|
Vital Signs | 1 | 2021 | 18 | 0.050 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 259 | 0.050 |
Why?
|
Internship and Residency | 2 | 2020 | 1152 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2024 | 552 | 0.040 |
Why?
|
Plasma Cells | 1 | 2019 | 47 | 0.040 |
Why?
|
Machine Learning | 1 | 2022 | 203 | 0.040 |
Why?
|
Urban Population | 1 | 2021 | 216 | 0.040 |
Why?
|
Caregivers | 1 | 2024 | 552 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2022 | 857 | 0.040 |
Why?
|
Vestibulocochlear Nerve Injuries | 1 | 2018 | 1 | 0.040 |
Why?
|
Facial Nerve Injuries | 1 | 2018 | 2 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2018 | 124 | 0.040 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2018 | 61 | 0.040 |
Why?
|
Gadolinium | 1 | 2018 | 102 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2022 | 404 | 0.040 |
Why?
|
Stents | 1 | 2022 | 685 | 0.040 |
Why?
|
Cerebrospinal Fluid Leak | 1 | 2017 | 40 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2019 | 774 | 0.030 |
Why?
|
Sutures | 1 | 2017 | 67 | 0.030 |
Why?
|
Cadaver | 1 | 2016 | 132 | 0.030 |
Why?
|
Hearing Tests | 1 | 2015 | 14 | 0.030 |
Why?
|
Remission, Spontaneous | 1 | 2015 | 68 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 2059 | 0.030 |
Why?
|
Watchful Waiting | 1 | 2015 | 59 | 0.030 |
Why?
|
Blood Loss, Surgical | 1 | 2015 | 136 | 0.030 |
Why?
|
Functional Laterality | 1 | 2015 | 178 | 0.030 |
Why?
|
Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2014 | 25 | 0.030 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2015 | 76 | 0.030 |
Why?
|
Microsurgery | 1 | 2015 | 69 | 0.030 |
Why?
|
Immunization Schedule | 1 | 2014 | 102 | 0.030 |
Why?
|
Vaccines, Conjugate | 1 | 2014 | 78 | 0.030 |
Why?
|
Ethmoid Sinus | 1 | 2014 | 9 | 0.030 |
Why?
|
Nose Neoplasms | 1 | 2014 | 31 | 0.030 |
Why?
|
Radiography | 1 | 2016 | 797 | 0.030 |
Why?
|
Orbit | 1 | 2014 | 103 | 0.030 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 2014 | 188 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2014 | 296 | 0.030 |
Why?
|
Hypertension | 1 | 2021 | 1264 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2014 | 865 | 0.030 |
Why?
|
Disease Progression | 1 | 2018 | 1970 | 0.020 |
Why?
|
Signal Transduction | 1 | 2024 | 4505 | 0.020 |
Why?
|
Acute Disease | 1 | 2014 | 1087 | 0.020 |
Why?
|
Chronic Disease | 1 | 2014 | 1147 | 0.020 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2010 | 55 | 0.020 |
Why?
|
Databases, Factual | 1 | 2014 | 1139 | 0.020 |
Why?
|
Obesity | 1 | 2020 | 2085 | 0.020 |
Why?
|
Robotics | 1 | 2010 | 110 | 0.020 |
Why?
|
Corneal Topography | 1 | 2009 | 191 | 0.020 |
Why?
|
Laryngoscopy | 1 | 2010 | 147 | 0.020 |
Why?
|
Refraction, Ocular | 1 | 2009 | 298 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 1241 | 0.020 |
Why?
|
Time Factors | 1 | 2014 | 5997 | 0.010 |
Why?
|
Risk Factors | 1 | 2014 | 9673 | 0.010 |
Why?
|